238 related articles for article (PubMed ID: 31041640)
21. Hypoxia-induced NIPP1 activation enhances metastatic potential and predicts poor prognosis in hepatocellular carcinoma.
Huang Y; Tao Y; Hu K; Lin F; Li X; Feng T; Wang ZM
Tumour Biol; 2016 Nov; 37(11):14903-14914. PubMed ID: 27644248
[TBL] [Abstract][Full Text] [Related]
22. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.
Zhao XL; Sun T; Che N; Sun D; Zhao N; Dong XY; Gu Q; Yao Z; Sun BC
J Cell Mol Med; 2011 Mar; 15(3):691-700. PubMed ID: 20219012
[TBL] [Abstract][Full Text] [Related]
23. The tumor suppressive miR-26a regulation of FBXO11 inhibits proliferation, migration and invasion of hepatocellular carcinoma cells.
Ma Y; Deng F; Li P; Chen G; Tao Y; Wang H
Biomed Pharmacother; 2018 May; 101():648-655. PubMed ID: 29518611
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
[TBL] [Abstract][Full Text] [Related]
25. Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma.
Gao Q; Zhu H; Dong L; Shi W; Chen R; Song Z; Huang C; Li J; Dong X; Zhou Y; Liu Q; Ma L; Wang X; Zhou J; Liu Y; Boja E; Robles AI; Ma W; Wang P; Li Y; Ding L; Wen B; Zhang B; Rodriguez H; Gao D; Zhou H; Fan J
Cell; 2019 Oct; 179(2):561-577.e22. PubMed ID: 31585088
[TBL] [Abstract][Full Text] [Related]
26. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.
Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J
Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125
[TBL] [Abstract][Full Text] [Related]
27. miR-122-5p Inhibits the Proliferation, Invasion and Growth of Bile Duct Carcinoma Cells by Targeting ALDOA.
Xu Z; Liu G; Zhang M; Zhang Z; Jia Y; Peng L; Zhu Y; Hu J; Huang R; Sun X
Cell Physiol Biochem; 2018; 48(6):2596-2606. PubMed ID: 30121648
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
Zhou M; Zhang XY; Yu X
Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
[TBL] [Abstract][Full Text] [Related]
29. Upregulated TRIO expression correlates with a malignant phenotype in human hepatocellular carcinoma.
Wang B; Fang J; Qu L; Cao Z; Zhou J; Deng B
Tumour Biol; 2015 Sep; 36(9):6901-8. PubMed ID: 25851347
[TBL] [Abstract][Full Text] [Related]
30. The mu-opioid receptor is a molecular marker for poor prognosis in hepatocellular carcinoma and represents a potential therapeutic target.
Chen DT; Pan JH; Chen YH; Xing W; Yan Y; Yuan YF; Zeng WA
Br J Anaesth; 2019 Jun; 122(6):e157-e167. PubMed ID: 30915986
[TBL] [Abstract][Full Text] [Related]
31. Activation of beta-catenin by hypoxia in hepatocellular carcinoma contributes to enhanced metastatic potential and poor prognosis.
Liu L; Zhu XD; Wang WQ; Shen Y; Qin Y; Ren ZG; Sun HC; Tang ZY
Clin Cancer Res; 2010 May; 16(10):2740-50. PubMed ID: 20460486
[TBL] [Abstract][Full Text] [Related]
32. Elevated UHRF1 expression contributes to poor prognosis by promoting cell proliferation and metastasis in hepatocellular carcinoma.
Liu X; Ou H; Xiang L; Li X; Huang Y; Yang D
Oncotarget; 2017 Feb; 8(6):10510-10522. PubMed ID: 28060737
[TBL] [Abstract][Full Text] [Related]
33. MiR-5692a promotes the invasion and metastasis of hepatocellular carcinoma via MMP9.
Sun SJ; Wang N; Sun ZW; Chen J; Cui HW
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4869-4878. PubMed ID: 30070322
[TBL] [Abstract][Full Text] [Related]
34. Nrf2 is a potential prognostic marker and promotes proliferation and invasion in human hepatocellular carcinoma.
Zhang M; Zhang C; Zhang L; Yang Q; Zhou S; Wen Q; Wang J
BMC Cancer; 2015 Jul; 15():531. PubMed ID: 26194347
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of NKX6.1 is closely associated with progressive features and predicts unfavorable prognosis in human primary hepatocellular carcinoma.
Huang LL; Zhang Y; Zhang JX; He LJ; Lai YR; Liao YJ; Tian XP; Deng HX; Liang YJ; Kung HF; Xie D; Zhu SL
Tumour Biol; 2015 Jun; 36(6):4405-15. PubMed ID: 25596704
[TBL] [Abstract][Full Text] [Related]
36. miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1.
Hua S; Lei L; Deng L; Weng X; Liu C; Qi X; Wang S; Zhang D; Zou X; Cao C; Liu L; Wu D
Oncogene; 2018 Mar; 37(12):1624-1636. PubMed ID: 29335523
[TBL] [Abstract][Full Text] [Related]
37. HIF-2-dependent expression of stem cell factor promotes metastasis in hepatocellular carcinoma.
Wang X; Dong J; Jia L; Zhao T; Lang M; Li Z; Lan C; Li X; Hao J; Wang H; Qin T; Huang C; Yang S; Yu M; Ren H
Cancer Lett; 2017 May; 393():113-124. PubMed ID: 28153790
[TBL] [Abstract][Full Text] [Related]
38. The long noncoding RNA AK002107 negatively modulates miR-140-5p and targets TGFBR1 to induce epithelial-mesenchymal transition in hepatocellular carcinoma.
Tang YH; He GL; Huang SZ; Zhong KB; Liao H; Cai L; Gao Y; Peng ZW; Fu SJ
Mol Oncol; 2019 May; 13(5):1296-1310. PubMed ID: 30943320
[TBL] [Abstract][Full Text] [Related]
39. RUNX2 promotes hepatocellular carcinoma cell migration and invasion by upregulating MMP9 expression.
Wang Q; Yu W; Huang T; Zhu Y; Huang C
Oncol Rep; 2016 Nov; 36(5):2777-2784. PubMed ID: 27666365
[TBL] [Abstract][Full Text] [Related]
40. Knockdown of SUMO1P3 represses tumor growth and invasion and enhances radiosensitivity in hepatocellular carcinoma.
Zhou Y; He P; Xie X; Sun C
Mol Cell Biochem; 2019 Jan; 450(1-2):125-134. PubMed ID: 29905911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
